In the present study, we examined the role of DSCAM-AS1 in endometrial cancer, employing both in silico and in vitro approaches, focusing on identification of genes and pathways regulated by this lncRNA using transcriptome and pathway analyses. Here, DSCAM is linked to endometrial cancer.